Market Structure and Advertising in the U.S. Pharmaceutical Industry
- 1 February 1978
- journal article
- Published by Wolters Kluwer Health in Medical Care
- Vol. 16 (2) , 90-109
- https://doi.org/10.1097/00005650-197802000-00002
Abstract
Distortions in market processes for pharmaceuticals raise the important policy problem of devising measures to improve industry performance. This paper first reviews the basic issues involved in formulating economic policy regarding the pharmaceutical industry. Methods for reducing structural market power and undesirable promotional expenditures are examined, and the impacts of four oft-suggested policy "reforms"--removal of trade names, removal of patents, relaxation of requirements for certification of new drug products, and increased enforcement of antitrust laws--are then analyzed. Finally, problems requiring additional research are identified.Keywords
This publication has 0 references indexed in Scilit: